Drug company boss urges inquiry into pharmaceutical pricing
A drug company head says the Government should hold an inquiry into the prices pharmaceutical firms charge for breast cancer drugs. Patients battling for new two new drugs had their calls for an inquiry into drug-buyer Pharmac turned down by MPs last week. Lance Gravatt says patients shouldn't have to plead, but drug prices are the problem and more scrutiny is needed. Here's our health correspondent, Karen Brown.